SCHEMBL7818903

SCHEMBL7818903

Cc1nc2c(o1)C(=O)c1ccccc1C2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP1 O94782 3/20 0.60
USP19 O94966 2/20 0.60
WDR48 Q8TAF3 1/20 0.60
UCHL3 P15374 1/20 0.54
USP8 P40818 2/20 0.51
USP2 O75604 1/20 0.51
OTUB1 Q96FW1 1/20 0.51
USP36 Q9P275 1/20 0.51
PTGS2 P35354 1/20 0.45
MAPT P10636 5/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
AHR P35869 1/20 0.44
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
HTT P42858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811858 0.80 USP1 (0.67) USP1USP19WDR48UCHL3USP8
SCHEMBL19198308 0.79 USP1 (0.57) USP1USP19WDR48UCHL3USP8
SCHEMBL7968066 0.77 USP1 (0.77) USP1USP19WDR48UCHL3USP8
SCHEMBL29629184 0.75 USP1 (1.00) USP1USP19WDR48UCHL3USP8
SCHEMBL29629183 0.75 USP1 (1.00) USP1USP19WDR48UCHL3USP8
SCHEMBL7808226 0.75 USP1 (1.00) USP1USP19WDR48UCHL3USP8
SCHEMBL16888427 0.75 MEN1 (0.55) KMT2A
SCHEMBL19856523 0.74 USP1 (0.55) USP1USP19WDR48UCHL3USP8
SCHEMBL7812967 0.74 USP1 (0.71) USP1USP19WDR48UCHL3USP8
SCHEMBL21498209 0.73 USP1 (0.64) USP1USP19WDR48UCHL3USP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190101676-A1 COLORING COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2019-04-04 US disclosed
US-9725425-B1 Compounds and methods for treating cancer DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-08-08 US disclosed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed